Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes
ABSTRACT The annual incidence of Lyme disease, caused by tick-transmitted Borreliella burgdorferi, is estimated to be at least 476,000 cases in the United States and many more worldwide. Ten to 20% of antimicrobial-treated Lyme disease patients display posttreatment Lyme disease syndrome (PTLDS), a...
Main Authors: | Felipe C. Cabello, Monica E. Embers, Stuart A. Newman, Henry P. Godfrey |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-06-01
|
Series: | mBio |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/mbio.03440-21 |
Similar Items
-
Reply to Luger, “Why Is It So Hard to Find Persistent Borreliella burgdorferi?”
by: Felipe C. Cabello, et al.
Published: (2022-10-01) -
Comparison of Lyme Disease in the United States and Europe
by: Adriana R. Marques, et al.
Published: (2021-08-01) -
Metamorphoses of Lyme disease spirochetes: phenomenon of Borrelia persisters
by: Natalie Rudenko, et al.
Published: (2019-05-01) -
The Long-Term Persistence of <i>Borrelia burgdorferi</i> Antigens and DNA in the Tissues of a Patient with Lyme Disease
by: Eva Sapi, et al.
Published: (2019-10-01) -
Lyme Disease: antibodies against Borrelia burgdorferi in farm workers in Argentina
by: Nestor Oscar Stanchi, et al.